I agree that this site is using cookies. You can find further informations here.
X
Hagino, Teppei
47  results:
Search for persons X
?
1

Dietary habits in adult Japanese patients with vitiligo:

Hamada, Risa ; Funasaka, Yoko ; Saeki, Hidehisa...
The Journal of Dermatology.  51 (2024)  4 - p. 491-508 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Effectiveness of Dose Increase in Upadacitinib from 15 mg t..:

Hagino, Teppei ; Hamada, Risa ; Yoshida, Mai...
Clinical Drug Investigation.  44 (2024)  4 - p. 261-269 , 2024
Link: https://doi.org/10.1007/..
 
?
3

The Usefulness of Atopic Dermatitis Control Tool in Upadaci..:

Hagino, Teppei ; Saeki, Hidehisa ; Fujimoto, Eita..
Dermatologic Therapy.  2024 (2024)  1 - p. , 2024
Link: https://doi.org/10.1155/..
 
?
4

Effectiveness of deucravacitinib for genital, nail, and sca..:

Hagino, Teppei ; Onda, Marina ; Saeki, Hidehisa..
Clinical and Experimental Dermatology.  , 2024
Link: https://doi.org/10.1093/..
 
?
5

Long-term effectiveness and safety of upadacitinib for Japa..:

Hagino, Teppei ; Saeki, Hidehisa ; Fujimoto, Eita.
Journal of Dermatological Treatment.  35 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
6

Total eosinophil count as a biomarker for therapeutic effec..:

Hagino, Teppei ; Hamada, Risa ; Yoshida, Mai...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
7

Author reply to the letter regarding 'Dietary habits in adu..:

Hamada, Risa ; Funasaka, Yoko ; Saeki, Hidehisa...
The Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
8

Predictive factors for responders to upadacitinib treatment..:

Hagino, Teppei ; Yoshida, Mai ; Hamada, Risa...
Journal of Dermatological Treatment.  35 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
9

Effectiveness and safety of deucravacitinib treatment for m..:

Hagino, Teppei ; Saeki, Hidehisa ; Fujimoto, Eita.
Journal of Dermatological Treatment.  35 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
10

Sustained Effectiveness of Upadacitinib in Moderate-to-Seve..:

Hagino, Teppei ; Hamada, Risa ; Yoshida, Mai...
Pharmaceuticals.  17 (2024)  4 - p. 519 , 2024
Link: https://doi.org/10.3390/..
 
?
11

Real‐world effectiveness and safety of bimekizumab in Japan..:

Hagino, Teppei ; Saeki, Hidehisa ; Fujimoto, Eita.
The Journal of Dermatology.  51 (2024)  5 - p. 649-658 , 2024
Link: https://doi.org/10.1111/..
 
?
12

Effects of Biologic Therapy on Laboratory Indicators of Car..:

Hagino, Teppei ; Saeki, Hidehisa ; Fujimoto, Eita.
Journal of Clinical Medicine.  12 (2023)  5 - p. 1934 , 2023
Link: https://doi.org/10.3390/..
 
?
13

Biomarkers and Predictive Factors for Treatment Response to..:

Hagino, Teppei ; Saeki, Hidehisa ; Kanda, Naoko
Journal of Clinical Medicine.  12 (2023)  3 - p. 974 , 2023
Link: https://doi.org/10.3390/..
 
?
14

Background factors predicting the occurrence of herpes zost..:

Hagino, Teppei ; Saeki, Hidehisa ; Fujimoto, Eita.
The Journal of Dermatology.  50 (2023)  10 - p. 1301-1312 , 2023
Link: https://doi.org/10.1111/..
 
?
15

Effectiveness of switching from baricitinib 4 mg to upadaci..:

Hagino, Teppei ; Yoshida, Mai ; Hamada, Risa...
Journal of Dermatological Treatment.  34 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
1-15